T. Menges et al., THE INFLUENCE OF DIFFERENT METHODS OF AUT OLOGOUS BLOOD-TRANSFUSION ON PLASMA-LEVELS OF ANTIBIOTICS - STUDY OF THE CEPHALOSPORINE CEFAMANDOLE, Anasthesist, 42(8), 1993, pp. 509-515
Infection after open heart surgery is a serious complication since era
dication of infection in these cases is difficult even with appropriat
e antibiotic therapy. In the attempt to avoid this problem, prophylact
ic administration of antibiotics is common. Their relative safety and
their broad spectrum of activity make cephalosporin antibiotics popula
r choices for prophylaxis prior to and during operations, including ca
rdiovascular procedures. Methods. Preoperative antibiotic prophylaxis
with 2 g cefamandole was performed in a prospective randomized study i
ncluding 62 male patients divided into three groups. All patients gave
informed consent, and the study was approved by the ethics committee
of the hospital. Patients in group 1 (n = 21) and group 2 (n = 21) und
erwent aortocoronary bypass (ACVB) with extracorporeal circulation (EC
C), while patients in group 3 (n = 20) had carotid surgery. Anaesthesi
a, coronary-bypass procedures and infusion regime were standardized. T
he flow rate during ECC was maintained at 2.4 l/min/m2 and the rectal
temperature between 33-degrees and 34-degrees-C. Arterial and urine sp
ecimens for the determination of plasma and urine levels of cefamandol
e were taken at definite times. Autologous blood salvage during operat
ion was performed with haemofiltration techniques (HF) in group 1 (HF
80, Fresenius, Bad Homburg, Germany) and with cell separation techniqu
es (CS) in group 2 (Hemonetics III, Hemonetics). Plasma and urine cefa
mandole levels were measured by high-pressure liquid chromatography (H
PLC). Results. After administration of 2 g cefamandole mean peak level
s of 404.6 +/- 141.7 mug/ml were seen. Because of haemodilution at the
beginning of extracorporeal circulation, group 1 and 2 showed much lo
wer cefamandole plasma levels, 22.1 +/- 11.6 mug/ml and 24.3 +/- 14.4
mug/ml, than group 3 (after the same time course), with 47.4 +/- 19.1
mug/ml. For all patients in group 1 and 2 prebypass time (70.3 +/- 22.
4 min) and the duration of the ECC (72.3 +/- 17.7 min) were comparable
. There was a significant correlation between prebypass time and cefam
andole plasma levels at the beginning of extracorporeal circulation (P
< 0.001). No correlation could be seen for the plasma concentration a
fter discontinuation of the extracorporeal circulation and the duratio
n of extracorporeal circulation. The volume of autologous red packed c
ells and the enclosed amount of cefamandole showed a significant diffe
rence (P < 0.001) between group 1 (1120.0 +/- 296.8 ml, 27.5 +/- 17.1
mg) and group 2 (734.3 +/- 186.6 ml, 2.9 +/- 3.2 mg). The plasma cefam
andole level after transfusion of autologous blood displayed a signifi
cant correlation (P < 0.01) with cefamandole concentration in the auto
logous red packed cells. Transfusion of the autologous blood produced
no significant increase in plasma cefamandole levels. With an operatio
n time of more than 2.5 h during ECC the cefamandole plasma level decr
eased below the necessary minimal inhibitory concentration (MIC90), pa
rticularly for gram-negative bacteria. Conclusion. Additional administ
ration of 1 g cefamandole shortly before the beginning of cardiopulmon
ary bypass is recommended, particularly for surgical procedures with E
CC of more than 2.5 h. Adjustment of drug dosage prior to or during su
rgery may be required to optimize therapy, but before this can be achi
eved precisely, more information on drug disposition during the operat
ive procedures is needed.